Jun 26, 2025, 13:45
Dr Sthanu Subramanian: Tenecteplase VS Alteplase – TNK Targets the Fibrin in Blood Clots More Effectively
Dr. Sthanu Subramanian shared a post on X:
“Tenecteplase (TNK) vs. Alteplase (tPA):
TNK targets the fibrin in blood clots more effectively.
This means it is less likely to activate the body’s natural clotting system elsewhere, potentially reducing the risk of bleeding complications.”
Read also Dr Sthanu Subramanian Highlights EMS Protocols for Managing Atrial Fibrillation.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera